{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:01:07Z","timestamp":1793037667372,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011450","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T00:00:00Z","timestamp":1516060800000}}],"reference-count":84,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011450.pub2","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T18:57:55Z","timestamp":1516129075000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis"],"prefix":"10.1002","author":[{"given":"Nadia","family":"Mohammed Vashist","sequence":"first","affiliation":[{"name":"PRA Health Sciences; 300-655 Tyee Road Victoria BC Canada V9A 6X5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Samaan","sequence":"additional","affiliation":[{"name":"Academic Medical Center; Meibergdreef 9 - C2-112 Amsterdam Netherlands 1105 AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud H","family":"Mosli","sequence":"additional","affiliation":[{"name":"King Abdulaziz University; King Abdulaziz University Hospital; Jeddah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E","family":"Parker","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials; 100 Dundas Street, Suite 200 London ON Canada N6A 5B6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K","family":"MacDonald","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials; Cochrane IBD Group; 100 Dundas Street, Suite 200 London ON Canada N6A 5B6"},{"name":"University of Western Ontario; Department of Medicine; London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid A","family":"Nelson","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials; San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GY","family":"Zou","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials; Cochrane IBD Group; 100 Dundas Street, Suite 200 London ON Canada N6A 5B6"},{"name":"University of Western Ontario; Department of Epidemiology and Biostatistics; London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G","family":"Feagan","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials; Cochrane IBD Group; 100 Dundas Street, Suite 200 London ON Canada N6A 5B6"},{"name":"University of Western Ontario; Department of Medicine; London ON Canada"},{"name":"University of Western Ontario; Department of Epidemiology and Biostatistics; London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Khanna","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials; 100 Dundas Street, Suite 200 London ON Canada N6A 5B6"},{"name":"University of Western Ontario; Department of Medicine; London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Jairath","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials; 100 Dundas Street, Suite 200 London ON Canada N6A 5B6"},{"name":"University of Western Ontario; Department of Medicine; London ON Canada"},{"name":"University of Western Ontario; Department of Epidemiology and Biostatistics; London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,1,16]]},"reference":[{"key":"10.1002\/14651858.CD011450.pub2-BIB0001|cit1","doi-asserted-by":"crossref","unstructured":"Burger DC Thomas SJ Walsh AJ Von Herbay A Buchell OC Keshav S Depth of remission may not predict outcome of UC over 2 years Gut 2011 A133","DOI":"10.1136\/gut.2011.239301.282"},{"issue":"11","key":"10.1002\/14651858.CD011450.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.dld.2014.07.010","article-title":"Interobserver agreement in IBD scores requires expertise and education: Preliminary results from an ongoing IG-IBD study","volume":"46","author":"Daperno","year":"2011","journal-title":"Digestive and Liver Disease"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD011450.pub2-BIB0003|cit3","first-page":"S","article-title":"Increasing interobserver agreement on IBD endoscopic scoring systems: results from the IGIBD Endo Educational Program","volume":"146","author":"Daperno","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-230X-4-9","article-title":"Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis","volume":"4","author":"Lange","year":"2004","journal-title":"BMC Gastroenterology"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/ibd.22879","article-title":"Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?","volume":"18","author":"Dhanda","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0006|cit6","doi-asserted-by":"crossref","unstructured":"Dhanda AD Greenwood R Creed TJ Probert CS Endoscopy can be avoided in the assessment of ulcerative colitis in clinical trials Gut 2011 A140 1","DOI":"10.1136\/gut.2011.239301.298"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1572-0241.2005.40641.x","article-title":"Is endoscopy necessary for the measurement of disease activity in ulcerative colitis?","volume":"100","author":"Higgins","year":"2005","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1443-1661.2009.00916.x","article-title":"Validity of activity indices in ulcerative colitis: comparison of clinical and endoscopic indices","volume":"22","author":"Hirai","year":"2010","journal-title":"Digestive Endoscopy"},{"issue":"3","key":"10.1002\/14651858.CD011450.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/ecco-jcc\/jjv210","article-title":"The ulcerative colitis endoscopic index of severity more accurately reflects clinical outcomes and long-term prognosis than the mayo endoscopic score","volume":"10","author":"Ikeya","year":"2016","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0010|cit10","first-page":"1432","article-title":"Are endoscopic grading and scoring systems in inflammatory bowel disease the same?","volume":"29","author":"Jun","year":"2008","journal-title":"Saudi Medical Journal"},{"issue":"8","key":"10.1002\/14651858.CD011450.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/gutjnl-2011-300695","article-title":"Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease","volume":"61","author":"Kiesslich","year":"2012","journal-title":"Gut"},{"issue":"5","key":"10.1002\/14651858.CD011450.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1016\/S0016-5085(14)60800-3","article-title":"Responsiveness of endoscopic indices in the evaluation of ulcerative colitis","volume":"146","author":"Levesque","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s00535-010-0244-2","article-title":"Novel endoscopic activity index is useful for choosing treatment in severe active ulcerative colitis patients","volume":"45","author":"Naganuma","year":"2010","journal-title":"Journal of Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD011450.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1136\/gut.2005.086900","article-title":"Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis","volume":"55","author":"Nishio","year":"2006","journal-title":"Gut"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.1111\/j.1440-1746.2008.05413.x","article-title":"Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis","volume":"23 Suppl 2","author":"Osada","year":"2008","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ibd.21000","article-title":"Comparison of several activity indices for the evaluation of endoscopic activity in UC: inter- and intraobserver consistency","volume":"16","author":"Osada","year":"2010","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0017|cit17","doi-asserted-by":"crossref","unstructured":"Rubin D Keyashian K Bunnag A Dave A Williams J Hanauer S Correlation between clinical, endoscopic, and histologic disease activity in ulcerative colitis American Journal of Gastroenterology 2012 S694","DOI":"10.14309\/00000434-201210001-01712"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cgh.2012.08.003","article-title":"Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures","volume":"11","author":"Samuel","year":"2013","journal-title":"Clinical Gastroenterology Hepatology"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/ibd.20986","article-title":"Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes","volume":"15","author":"Schoepfer","year":"2009","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0020|cit20","unstructured":"Thomas SJ Walsh A Von Herbay A Burchell O Brain O Keshav S How much agreement is there between histological, endoscopic and clinical assessments of remission in ulcerative colitis? Gut 2009 A101 2"},{"issue":"5","key":"10.1002\/14651858.CD011450.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.gastro.2013.07.024","article-title":"Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity","volume":"145","author":"Travis","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0022|cit22","doi-asserted-by":"crossref","unstructured":"Walsh AJ Brain AOS Keshav S Buchel OC Jacobovits S Merrin B How variable is the Mayo score between observers and might this affect trial recruitment or outcome? Journal of Gastroenterology and Hepatology 2009 A230","DOI":"10.1016\/S0016-5085(09)63118-8"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0023|cit23","doi-asserted-by":"crossref","unstructured":"Walsh AJ Brain AOS Keshav S Buchel OC Jacobovits S Merrin B Which activity index for ulcerative colitis? Evaluation of inter-observer variation in clinical, endoscopic and composite indices Gut 2009 A15","DOI":"10.1016\/S1873-9946(09)60113-6"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0024|cit24","doi-asserted-by":"crossref","unstructured":"Blonski W Osterman MT Lin MV Brensinger CM Sonu I Lichtenstein G An update: which endoscopic or clinical factor is most predictive of future disease course in patients with ulcerative colitis? Gastroenterology 2011 S358 9","DOI":"10.1016\/S0016-5085(10)61653-8"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0025|cit25","unstructured":"Hameed K Khan IU Farooqui JI Shah S Correlation of endoscopic extent and severity with the clinical presentation of ulcerative colitis Journal of the College of Physicians and Surgeons Pakistan 2001 551 4"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1440-1746.2010.06562.x","article-title":"Is sigmoidoscopy sufficient for evaluating inflammatory status of ulcerative colitis patients?","volume":"26","author":"Kato","year":"2011","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nrgastro.2012.198","article-title":"Ulcerative colitis: UCCIS - A reproducible tool to assess mucosal healing","volume":"9","author":"Neumann","year":"2012","journal-title":"Nature Reviews Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0028|cit28","unstructured":"Ohkusa T Osada T Terai T Sato N Okayasu I Current opinion of activity index for colonoscopic and histological findings in ulcerative colitis: A proposal of new activity assessment by cumulative method of seven points scores Gastroenterological Endoscopy 2006 977 86"},{"issue":"6","key":"10.1002\/14651858.CD011450.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/BF01296733","article-title":"Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis","volume":"27","author":"Powell-Tuck","year":"1982","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0030|cit30","doi-asserted-by":"crossref","unstructured":"Travis S Sandborn WJ Hanauer SB Lemann M Sands BE Marteau P Identification of items to be included in an ulcerative colitis endoscopic index of severity (UCEIS) Gastroenterology 2009 A160","DOI":"10.1016\/S0016-5085(09)60722-8"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/gutjnl-2011-300486","article-title":"Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)","volume":"61","author":"Travis","year":"2011","journal-title":"Gut"},{"issue":"6","key":"10.1002\/14651858.CD011450.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.gie.2017.03.012","article-title":"Development and reliability of the new endoscopic virtual chromoendoscopy score: the PICaSSO score","volume":"86","author":"Iacucci","year":"2017","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"5832051","DOI":"10.1155\/2016\/5832051","article-title":"Correlation between histological activity and endoscopic, clinical, and serologic activities in patients with ulcerative colitis","volume":"2016","author":"Kim","year":"2016","journal-title":"Gastroenterology Research and Practice"},{"issue":"Supp 1","key":"10.1002\/14651858.CD011450.pub2-BIB0034|cit34","first-page":"S157","article-title":"Validation of ulcerative colitis endoscopic index of severity (UCEIS) in Korea","volume":"10","author":"Lee","year":"2016","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0035|cit35","first-page":"225","article-title":"Quantitative endoscopic and histologic activity assessment of ulcerative colitis","volume":"72","author":"Songur","year":"2009","journal-title":"Acta Gastro-enterologica Belgica"},{"issue":"21","key":"10.1002\/14651858.CD011450.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011450.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s10620-005-1590-4","article-title":"Proposal of a new clinical index predictive of endoscopic severity in ulcerative colitis","volume":"50","author":"Azzolini","year":"2005","journal-title":"Digestive Disease and Sciences"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0038|cit38","volume-title":"The management of colitis","author":"Bargen","year":"1935"},{"issue":"5375","key":"10.1002\/14651858.CD011450.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/bmj.1.5375.89","article-title":"Variation between observers in describing mucosal appearances in proctocolitis","volume":"1","author":"Baron","year":"1964","journal-title":"British Medical Journal"},{"issue":"9573","key":"10.1002\/14651858.CD011450.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD011450.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00005176-199605000-00006","article-title":"Endoscopic assessment of the colonic response to corticosteroids in children with ulcerative colitis","volume":"22","author":"Beattie","year":"1996","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"7","key":"10.1002\/14651858.CD011450.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/00365521.1970.12096647","article-title":"A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis","volume":"5","author":"Binder","year":"1970","journal-title":"Scandanavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0043|cit43","article-title":"Inflammatory bowel disease","volume-title":"Endoscopic interpretation: normal and pathologic appearances of the gastrointestinal tract","author":"Blackstone","year":"1984"},{"issue":"7","key":"10.1002\/14651858.CD011450.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1007\/BF02088063","article-title":"Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity","volume":"39","author":"Carbonnel","year":"1994","journal-title":"Digestive Diseases and Sciences"},{"issue":"1","key":"10.1002\/14651858.CD011450.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychological Bulletin"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1745-6215-8-17","article-title":"Outcome measurement in clinical trials for Ulcerative Colitis:towards standardisation","volume":"8","author":"Cooney","year":"2007","journal-title":"Trials"},{"issue":"2","key":"10.1002\/14651858.CD011450.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.gastro.2006.12.038","article-title":"A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis","volume":"132","author":"D'Haens","year":"2007","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD011450.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3109\/00365528708991947","article-title":"A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis","volume":"22","author":"Danielsson","year":"1987","journal-title":"Scandanavian Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD011450.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11938-017-0130-6","article-title":"Treat to target in inflammatory bowel disease: an updated review of the literature","volume":"15","author":"Darr","year":"2017","journal-title":"Current Treatment Options in Gastroenterology"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD011450.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"142S","DOI":"10.1016\/S0197-2456(05)80019-4","article-title":"Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation","volume":"12","author":"Deyo","year":"1991","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/gut.5.5.437","article-title":"Controlled trial of sulphasalazine in the treatment of ulcerative colitis","volume":"5","author":"Dick","year":"1964","journal-title":"Gut"},{"issue":"24","key":"10.1002\/14651858.CD011450.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa042982","article-title":"Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin","volume":"352","author":"Feagan","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011450.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2013.03.025","article-title":"The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis","volume":"145","author":"Feagan","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD011450.pub2-BIB0054|cit54","first-page":"412","article-title":"5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial","volume":"81","author":"Friedman","year":"1986","journal-title":"American Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD011450.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2007.05.051","article-title":"Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort","volume":"133","author":"Fr\u00f8slie","year":"2007","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD011450.pub2-BIB0056|cit56","first-page":"1188","article-title":"Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group","volume":"88","author":"Hanauer","year":"1993","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD011450.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1053\/j.gastro.2004.02.071","article-title":"Medical therapy for ulcerative colitis 2004","volume":"126","author":"Hanauer","year":"2004","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD011450.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/gut.2004.056358","article-title":"Patient defined dichotomous endpoints for remission and clinical improvement in ulcerative colitis","volume":"54","author":"Higgins","year":"2005","journal-title":"Gut"},{"issue":"3","key":"10.1002\/14651858.CD011450.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00042737-200203000-00007","article-title":"Octreotide in patients with active ulcerative colitis treated with high dose corticosteroids (OPUS I)","volume":"14","author":"Jeroen","year":"2002","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"12","key":"10.1002\/14651858.CD011450.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11894-015-0470-0","article-title":"Endoscopic disease activity in inflammatory bowel disease","volume":"17","author":"Ket","year":"2015","journal-title":"Current Gastroenterology Reports"},{"issue":"1","key":"10.1002\/14651858.CD011450.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"issue":"5","key":"10.1002\/14651858.CD011450.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1444-51","DOI":"10.1016\/0016-5085(92)91163-X","article-title":"Colorectal cancer risk and mortality in patients with ulcerative colitis","volume":"103","author":"Langholz","year":"1992","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD011450.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2036.1995.tb00421.x","article-title":"Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis","volume":"9","author":"Lemann","year":"1995","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD011450.pub2-BIB0064|cit64","first-page":"1398","article-title":"A randomised, double blind, dose response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis","volume":"97","author":"Levine","year":"2002","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD011450.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/00365520212512","article-title":"Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis","volume":"37","author":"Lindgren","year":"2002","journal-title":"Scandanavian Journal of Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD011450.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/ecco-jcc\/jjv111","article-title":"The modified Mayo endoscopic score (MMES): a new index for the assessment of extension and severity of endoscopic activity in ulcerative colitis patients","volume":"9","author":"Lobat\u00f3n","year":"2015","journal-title":"Journal of Crohn's and Colitis"},{"issue":"6","key":"10.1002\/14651858.CD011450.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2036.1994.tb00340.x","article-title":"Budesonide versus prednisolone retention enemas in active distal ulcerative colitis","volume":"8","author":"L\u00f6fberg","year":"1994","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"20","key":"10.1002\/14651858.CD011450.pub2-BIB0068|cit68","first-page":"763","article-title":"Ulcerative colitis. Activity index for the clinical and histological classification of inflammatory activity","volume":"118","author":"Maier","year":"1988","journal-title":"Schweizerische Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD011450.pub2-BIB0069|cit69","first-page":"393-407","article-title":"The value of rectal biopsy in the diagnosis of ulcerative colitis","volume":"30","author":"Matts","year":"1961","journal-title":"Quarterly Journal of Medicine"},{"issue":"12 Suppl","key":"10.1002\/14651858.CD011450.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"76S","DOI":"10.1007\/BF01312469","article-title":"Proctocolitis unresponsive to conventional therapy. Response to 5-aminosalicylic acid enemas","volume":"32","author":"McPhee","year":"1987","journal-title":"Digestive Diseases and Sciences"},{"issue":"3","key":"10.1002\/14651858.CD011450.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/gastro\/gou028","article-title":"Colonoscopic evaluation in ulcerative colitis","volume":"2","author":"Paine","year":"2014","journal-title":"Gastroentoerology Report"},{"issue":"6666","key":"10.1002\/14651858.CD011450.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","article-title":"Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial","volume":"298","author":"Rachmilewitz","year":"1989","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD011450.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","article-title":"Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis","volume":"126","author":"Rutter","year":"2004","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD011450.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/MIB.0000000000000046","article-title":"A systematic review of the measurement of endoscopic healing in ulcerative colitis clinical trials: recommendations and implications for future research","volume":"20","author":"Samaan","year":"2014","journal-title":"Inflammatory Bowel Diseases"},{"issue":"5 Part 1","key":"10.1002\/14651858.CD011450.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0016-5085(86)90376-8","article-title":"Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology and fecal indium 111-granulocyte excretion","volume":"90","author":"Saverymuttu","year":"1986","journal-title":"Gastroenterology"},{"issue":"26","key":"10.1002\/14651858.CD011450.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study","volume":"317","author":"Schroeder","year":"1987","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD011450.pub2-BIB0077|cit77","first-page":"971","article-title":"An index of disease activity in patients with ulcerative colitis","volume":"87","author":"Seo","year":"1992","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD011450.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/0016-5085(87)90621-4","article-title":"5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis","volume":"92","author":"Sutherland","year":"1987","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD011450.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/gutjnl-2011-300486","article-title":"Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)","volume":"61","author":"Travis","year":"2012","journal-title":"Gut"},{"issue":"4947","key":"10.1002\/14651858.CD011450.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis; final report on a therapeutic trial","volume":"2","author":"Truelove","year":"1955","journal-title":"British Medical Journal"},{"issue":"4979","key":"10.1002\/14651858.CD011450.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1315-8","DOI":"10.1136\/bmj.1.4979.1315","article-title":"Biopsy studies in ulcerative colitis","volume":"1","author":"Truelove","year":"1956","journal-title":"British Medical Journal"},{"issue":"5 Part 2","key":"10.1002\/14651858.CD011450.pub2-BIB0082|cit82","first-page":"A1679","article-title":"Comparison of enemas containing beclomethasone-di-propionate (BDP) or prednisolone 21-phosphate (PF) in the treatment of distal ulcerative colitis","volume":"92","author":"Heide","year":"1987","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD011450.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A simple clinical colitis activity index","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut"},{"issue":"6","key":"10.1002\/14651858.CD011450.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s11136-004-0027-4","article-title":"Quantifying responsiveness of quality of life measures without an external criterion","volume":"14","author":"Zou","year":"2005","journal-title":"Quality of Life Research"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011450.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:56:22Z","timestamp":1628549782000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD011450.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane IBD Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,16]]},"references-count":84,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011450.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,16]]}}}